within Pharmacolibrary.Drugs.ATC.V;

model V09IX13
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.16666666666666666,
    adminDuration  = 600,
    adminMass      = 0.37,
    adminCount     = 1,
    Vd             = 0.0002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Methionine (11C) is a radiolabeled form of the essential amino acid methionine, used as a positron emission tomography (PET) tracer in oncology to image protein synthesis in tumors, particularly gliomas and other brain tumors. It is not a therapeutic drug, but a diagnostic radiopharmaceutical and is not approved for therapeutic use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic estimates are based on published PET imaging literature and radiopharmaceutical handling in adult humans without significant comorbidities; direct compartmental PK values are generally not published, so values are estimated by analogy to similar tracers and compartmental modeling in PET research.</p><h4>References</h4><ol><li><p>Deloar, HM, et al., &amp; Watanuki, S (1998). Estimation of internal absorbed dose of L-[methyl-11C]methionine using whole-body positron emission tomography. <i>European journal of nuclear medicine</i> 25(6) 629–633. DOI:<a href=&quot;https://doi.org/10.1007/s002590050265&quot;>10.1007/s002590050265</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9618578/&quot;>https://pubmed.ncbi.nlm.nih.gov/9618578</a></p></li><li><p>Miyake, K, et al., &amp; Tamiya, T (2012). Usefulness of L-[methyl-11c]methionine positron emission tomography in the treatment of idiopathic hypertrophic cranial pachymeningitis--case report. <i>Neurologia medico-chirurgica</i> 52(10) 765–769. DOI:<a href=&quot;https://doi.org/10.2176/nmc.52.765&quot;>10.2176/nmc.52.765</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23095274/&quot;>https://pubmed.ncbi.nlm.nih.gov/23095274</a></p></li><li><p>Kaste, SC, et al., &amp; Shulkin, BL (2017). Comparison of . <i>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</i> 58(3) 419–424. DOI:<a href=&quot;https://doi.org/10.2967/jnumed.116.178640&quot;>10.2967/jnumed.116.178640</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27609791/&quot;>https://pubmed.ncbi.nlm.nih.gov/27609791</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V09IX13;
